Literature DB >> 16828178

The glucose-6-phosphate dehydrogenase from Trypanosoma cruzi: its role in the defense of the parasite against oxidative stress.

Mariana Igoillo-Esteve1, Juan José Cazzulo.   

Abstract

The Trypanosoma cruzi glucose-6-phosphate dehydrogenase (G6PDH) is encoded by several genes located in three of the parasite chromosomes. All the sequences present two possible start codons, 111bp apart, also present in its Trypanosoma brucei counterpart. As the 37 residues comprised between the two candidate initiator methionines of T. brucei and T. cruzi G6PDHs constitute an unusual N-terminal extension only present in trypanosomatids, two forms of the T. cruzi G6PDH were expressed in Escherichia coli: a long one (Tc-G6PDH-L) translated from the first ATG codon, and a short one (Tc-G6PDH-S) translated from the second. Both were purified and their kinetic constants determined. The apparent K(m) for glucose-6-phosphate was 189.9, 98.4, and 288microM, for Tc-G6PDH-L, Tc-G6PDH-S and native Tc-G6PDH, respectively. The apparent K(m) for NADP was similar for both recombinant proteins. The Tc-G6PDH-L as well as the native enzyme, was inactivated by DTT while the Tc-G6PDH-S was unaffected by the reducing agent. This behavior could be related to the presence of two Cys groups in the N-terminal extension of the Tc-G6PDH-L similarly to the redox regulated G6PDHs from chloroplasts and cyanobacteria. This property, together with a remarkable induction (up to 46-fold) of the T. cruzi G6PDH in metacyclic trypomastigotes under oxidative stress conditions, suggests that the enzyme may play a prominent role in the defense mechanisms of the parasite against oxidative stress becoming an important target for chemotherapy. Western blots using antibodies against the N-terminal extension in Tc-G6PDH-L show that this form is expressed in the parasite.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828178     DOI: 10.1016/j.molbiopara.2006.05.009

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  10 in total

1.  Expression, crystallization and preliminary X-ray crystallographic analysis of glucose-6-phosphate dehydrogenase from the human pathogen Trypanosoma cruzi in complex with substrate.

Authors:  Cecilia Ortíz; Nicole Larrieux; Andrea Medeiros; Horacio Botti; Marcelo Comini; Alejandro Buschiazzo
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

Review 2.  Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease.

Authors:  Lucía Piacenza; Gonzalo Peluffo; María Noel Alvarez; Alejandra Martínez; Rafael Radi
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

3.  Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression.

Authors:  Lucía Piacenza; Florencia Irigoín; María Noel Alvarez; Gonzalo Peluffo; Martin C Taylor; John M Kelly; Shane R Wilkinson; Rafael Radi
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

4.  The Role of Heme and Reactive Oxygen Species in Proliferation and Survival of Trypanosoma cruzi.

Authors:  Marcia Cristina Paes; Daniela Cosentino-Gomes; Cíntia Fernandes de Souza; Natália Pereira de Almeida Nogueira; José Roberto Meyer-Fernandes
Journal:  J Parasitol Res       Date:  2011-10-09

5.  Glucose-6-phosphate dehydrogenase of trypanosomatids: characterization, target validation, and drug discovery.

Authors:  Shreedhara Gupta; Mariana Igoillo-Esteve; Paul A M Michels; Artur T Cordeiro
Journal:  Mol Biol Int       Date:  2011-04-04

6.  Structure, kinetic characterization and subcellular localization of the two ribulose 5-phosphate epimerase isoenzymes from Trypanosoma cruzi.

Authors:  Soledad Natalia Gonzalez; Wanda Mariela Valsecchi; Dante Maugeri; José María Delfino; Juan José Cazzulo
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

7.  Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning.

Authors:  Melissa F Adasme; Sarah Naomi Bolz; Lauren Adelmann; Sebastian Salentin; V Joachim Haupt; Adriana Moreno-Rodríguez; Benjamín Nogueda-Torres; Verónica Castillo-Campos; Lilián Yepez-Mulia; José A De Fuentes-Vicente; Gildardo Rivera; Michael Schroeder
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

Review 8.  The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.

Authors:  Anna Stincone; Alessandro Prigione; Thorsten Cramer; Mirjam M C Wamelink; Kate Campbell; Eric Cheung; Viridiana Olin-Sandoval; Nana-Maria Grüning; Antje Krüger; Mohammad Tauqeer Alam; Markus A Keller; Michael Breitenbach; Kevin M Brindle; Joshua D Rabinowitz; Markus Ralser
Journal:  Biol Rev Camb Philos Soc       Date:  2014-09-22

9.  Slight temperature changes cause rapid transcriptomic responses in Trypanosoma cruzi metacyclic trypomastigotes.

Authors:  Lissa Cruz-Saavedra; Marina Muñoz; Luz Helena Patiño; Gustavo A Vallejo; Felipe Guhl; Juan David Ramírez
Journal:  Parasit Vectors       Date:  2020-05-14       Impact factor: 3.876

10.  Genome-scale metabolic models highlight stage-specific differences in essential metabolic pathways in Trypanosoma cruzi.

Authors:  Isabel S Shiratsubaki; Xin Fang; Rodolpho O O Souza; Bernhard O Palsson; Ariel M Silber; Jair L Siqueira-Neto
Journal:  PLoS Negl Trop Dis       Date:  2020-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.